Country Guide: Filing a Patent in Canada (CIPO)

Canada is the world's 10th-largest economy, a major trading partner of the United States, and a jurisdiction where patent protection provides genuine commercial value across natural resources, agriculture, cleantech, pharmaceuticals, AI, and advanced manufacturing. For US-based inventors, Canada is often the first international filing after the domestic US application — the geographic proximity, shared language, and deep economic integration under CUSMA (formerly NAFTA) make it a natural extension.

The Hard Truth About Canadian Patents

Canada's patent system is functional and predictable — but slow. The Canadian Intellectual Property Office (CIPO) has historically carried a significant examination backlog, with average times to first examination action of 2–4 years. This has improved with recent hiring and digitalisation initiatives, but Canadian prosecution remains slower than the USPTO, JPO, or KIPO.

The second challenge: Canada does not have a utility model or petty patent system. There is no fast-track registration equivalent to Germany's Gebrauchsmuster or China's utility model. The only route to patent protection is full substantive examination — meaning there is no interim enforceable right while waiting for grant.

Canada has also been the site of significant jurisprudence on the "promise of the patent" doctrine — a now-resolved legal theory that invalidated patents whose specifications "promised" a utility that was not fully demonstrated at the time of filing. The Supreme Court of Canada's decision in AstraZeneca v Apotex (2017) eliminated this doctrine, restoring the standard utility threshold. But the legacy of the promise doctrine means that Canadian specifications should be drafted carefully to avoid overpromising results that are not demonstrated in the specification.

CIPO: Overview

The Canadian Intellectual Property Office, headquartered in Gatineau, Quebec, administers patents, trademarks, copyrights, industrial designs, and integrated circuit topographies.

Annual filings: Approximately 35,000–40,000 patent applications per year, with foreign applicants accounting for approximately 85–90%.

Types of Patent Protection

Patent:

• Term: 20 years from filing date
• Examination: Full substantive examination
• Certificate of Supplementary Protection (CSP): Available for pharmaceutical patents — up to 2 years of additional protection for regulatory delay (introduced in 2017 under the Canada-EU CETA agreement)

No utility model system. Canada does not offer utility models, petty patents, or any equivalent fast-track registration.

Industrial Design: Protects visual features of a finished article. Term: 15 years from registration (amended in 2018, previously 10 years). Canada joined the Hague Agreement in 2018, allowing international design applications to designate Canada.

What Is Patentable in Canada

Canadian patentability requirements follow standard TRIPS criteria — novelty, inventive step (non-obviousness), and utility — with some notable distinctions:

Software: Computer-implemented inventions are patentable in Canada if they produce a "practical application" — broadly similar to the US post-Alice framework. Pure business methods and abstract algorithms are not patentable. The Canadian Patent Office Guidelines on Computer-Implemented Inventions (updated 2020) provide examination guidance.

Medical methods: Methods of medical treatment are patentable in Canada — unlike the EPO, Japan, India, and many other jurisdictions. This makes Canada attractive for medical device and pharmaceutical method claims that are excluded elsewhere.

Higher life forms: The Supreme Court of Canada's decision in Harvard College v Canada (Commissioner of Patents) (2002) held that higher life forms (multicellular organisms) are not patentable — though the genes, cell lines, and processes used to create them are. Microorganisms are patentable.

Grace period: Canada provides a 12-month grace period for the inventor's own disclosures — similar to the US AIA grace period. However, relying on this for international filing strategy is risky — the grace period does not apply at the EPO, GCC, or most non-North American offices.

Filing Process

Route 1: Direct Filing at CIPO

File directly through CIPO's online system. Applications may be filed in English or French. No local patent agent is required for Canadian residents; foreign applicants must appoint a registered Canadian patent agent.

Government fees (approximate, CAD):

• Filing fee: CAD $400–$800 (small entity / standard entity)
• Examination request fee: CAD $800–$1,600
• Final fee (grant): CAD $300–$600
• Annual maintenance fees: escalating from CAD $100/year (years 2–4) to CAD $450/year (years 15–19)

Route 2: PCT National Phase Entry

Deadline: 30 months from international priority date. English or French translation required. Appointment of a Canadian patent agent required for foreign applicants.

Examination Request

Examination must be requested within 5 years of the Canadian filing date — one of the longest examination request windows of any major office. This allows substantial time to assess commercial viability before committing to examination costs.

Accelerated Examination

CIPO offers accelerated examination for applications where the applicant has made the invention available commercially in Canada, or for green technology. The Patent Prosecution Highway (PPH) is available with the USPTO, EPO, JPO, KIPO, CNIPA, and other partner offices — providing significant acceleration based on a positive examination result elsewhere.

Costs: Realistic Breakdown

Enforcement

Patent infringement actions are heard exclusively by the Federal Court of Canada — provincial courts do not have jurisdiction over patent disputes. Canada's patent litigation system is well-developed, with experienced judges and predictable outcomes. Litigation costs are significantly lower than in the US — typically CAD $500,000–$2,000,000 for a fully contested case through trial — but higher than in many European jurisdictions.

Preliminary Injunctions

Interlocutory injunctions are available under the standard RJR-MacDonald three-part test: the applicant must demonstrate a serious question to be tried, that irreparable harm would result without the injunction, and that the balance of convenience favours granting relief. Courts grant preliminary injunctions in patent cases, but they are not routine — the irreparable harm threshold requires evidence beyond the mere fact of infringement.

Damages and Remedies

Successful patentees can recover either lost profits or a reasonable royalty — but not both. The Federal Court may also award an accounting of the infringer's profits as an alternative to damages. Punitive damages are rare in Canadian patent cases. Costs awards (partial recovery of legal fees) are standard, though they typically cover only a fraction of actual legal expenses.

PM(NOC) Proceedings

Canada has a PM(NOC) regime — the Patented Medicines (Notice of Compliance) Regulations — which provides a mechanism for pharmaceutical patent holders to delay generic drug approval, analogous to the US Hatch-Waxman framework. This is a specialised proceeding with strict timelines and is relevant primarily for pharmaceutical inventors.

Litigation Timelines

A contested patent infringement action in the Federal Court typically takes 2–4 years from filing to trial. Summary judgment and simplified action procedures are available for less complex cases.

Strategic Considerations

The US-Canada coordination question. For US-based inventors, the question is not whether to file in Canada — it is when and how. If your invention has commercial value in the US, it almost certainly has commercial value in Canada. The deep economic integration under CUSMA means that products crossing the border without Canadian patent protection are exposed to copying by Canadian competitors or distributors.

Use the 5-year examination window strategically. Canada's 5-year deadline for requesting examination is one of the longest of any major office. This allows you to defer examination costs until you have a clearer picture of commercial viability. If the invention does not prove commercially valuable, you can abandon the application without ever paying examination fees.

PPH is your best tool for acceleration. If you have a granted US patent or a positive examination result from the USPTO, EPO, JPO, or KIPO, the Patent Prosecution Highway allows you to fast-track Canadian examination. PPH prosecution typically results in a first office action within 6–12 months and grant within 12–24 months — dramatically faster than standard prosecution.

Draft specifications carefully — the promise doctrine legacy. Although the Supreme Court eliminated the promise doctrine in 2017, Canadian patent agents remain cautious about specification language. Avoid making specific performance claims in the specification that are not demonstrated by the data presented. State utility in measured, supportable terms.

Small entity status saves real money. CIPO's small entity fees are approximately 50% of standard fees across every stage — filing, examination, maintenance. If you qualify (fewer than 50 employees, or a university), the savings over 20 years are substantial.

Common Mistakes

Forgetting to request examination. Unlike the US (where examination is automatic), Canada requires a separate examination request within 5 years. Miss this deadline and the application is deemed abandoned. Calendar it.

Ignoring maintenance fees. Canadian patents require annual maintenance fees from years 2 through 19. The fees escalate significantly in later years. Failure to pay any single maintenance fee on time can result in the patent lapsing — and while late payment is possible with surcharges, it adds unnecessary risk and cost.

Assuming US and Canadian claim scope are identical. They are not. Canadian claim construction follows different jurisprudence (Free World Trust v Électro Santé, 2000 SCC). Claims are construed purposively, with reference to the specification and the person skilled in the art. US-drafted claims should be reviewed by a Canadian agent for local claim construction implications.

Relying on the grace period for international strategy. Canada's 12-month grace period is generous — but it does not exist at the EPO, the GCC offices, or most Asian offices. If you disclose your invention before filing and then try to extend protection beyond North America, the grace period will not save you in most foreign jurisdictions.

Filing in English without considering French. CIPO accepts both languages, and most applicants file in English. But if your commercial interest is in Quebec — Canada's second-largest province and a significant manufacturing and pharmaceutical market — having French-language marketing materials that align with your patent claims can be commercially useful.

Sources

1. Canadian Intellectual Property Office (CIPO) — Official patent office; filing procedures, fee schedules, and examination guidelines
2. Canada Patent Act — Statutory framework for Canadian patent law
3. WIPO — Canada Country Profile — Treaty memberships and IP office information
4. Canadian Patent Database — Free patent search database

Information current as of April 2026. Patent fees, timelines, and office procedures change — verify with the national patent office before filing.